Object Recognition And Morris Water Maze To Detect Cognitive Impairment From Neurodegenerative Diseases In Rats.
Main Article Content
Abstract
Cognitive dysfunction refers to a variety of learning disabilities that affect problem solving, language, attention, memory, and decision making. Cognitive impairment occurs in a variety of neurological diseases, including Alzheimer's disease, frontotemporal dementia, focal dementia, and Parkinson's disease. Cognitive impairment is a condition in which people have difficulty remembering, learning, reasoning, and making decisions about new things that affect their daily lives. A cognitive disorder refers to a disorder of one or more cognitive functions, and depending on the severity of the disorder, it can be classified into mild mental disorders and dementia. Treatments for learning disabilities include physical activity, cognitive training and exercise, and proper sleep and relaxation techniques can be beneficial for mental health. The Mediterranean diet may help people with mental disorders. The Morris water maze (MWM) is a comprehensive learning test for rats that relies on long distances from a starting point along the perimeter of an open swimming area to find an underwater discharge platform, and the MWM is one of the most widely used paradigms. Assess hippocampus-based learning and memory. The MWM test has become one of the most widely used research tools in various areas of behavioral neuroscience. This review details the Morris water maze model, risk factors, current treatments, and animal studies in psychological disorders
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Liu C, Oikonomopoulos A, Sayed N & Wu JC Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond. Development 2018;145.
Dawson TM, Golde TE, Lagier-Tourenne C. Animal models of neurodegenerative diseases. Nat Neurosci. 2018 Oct;21(10):1370-1379.
Zhang S, Shen L, Jiao B. Cognitive Dysfunction in Repeat Expansion Diseases: A Review. Front Aging Neurosci. 2022;14:841711.
Paulson H. Repeat expansion diseases. Handb. Clin. Neurol. 2018;147:105–123.
Awad N, Gagnon M, Messier C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol. 2004;26:1044–80.
Huang C-J, Hsieh H-M, Tu H-P, Jiang H-J, Wang P-W, Lin C-H. Generalized anxiety disorder in type 2 diabetes mellitus: prevalence and clinical characteristics. Braz J Psychiatry. 2020;42:621–9.
Munshi MN. Cognitive dysfunction in older adults with diabetes: what a clinician needs to know. Diabetes Care. 2017;40:461–7.
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimer's Dement. 2018;14:535–562.
Jessen, F., Amariglio, R. E., Buckley, R. F., van der Flier, W. M., Han, Y., Molinuevo, J. L., et al. The characterisation of subjective cognitive decline. Lancet Neurol. 2020;19: 271–278.
Petersen, R. C. Mild cognitive impairment. Lancet. 2006;367:2009.
Ramos, H., Moreno, L., Gil, M., García-Lluch, G., Sendra-Lillo, J., Alacreu, M., et al. Pharmacists' knowledge of factors associated with dementia: The a-to-z dementia knowledge list. Int. J. Environ. Res. Public Health. 2021;1:18.
Warren, S. L., Reid, E., Whitfield, P., and Moustafa, A. A subjective memory complaints as a predictor of mild cognitive impairment and Alzheimer's disease. Discov Psychol. 2022;2.
Lee, G. J., Do, C., and Suhr, J. A. Effects of personal dementia exposure on subjective memory concerns and dementia worry. Aging Neuropsychol. Cogn. 2021;28:855–870.
Morley JE, Morris JC, Berg-Weger M, et al. Brain health: the importance of recognizing cognitive impairment: an IAGG consensus conference. J Am Med Dir Assoc. 2015 Sep 01;16(9):731-9.
Lopez OL. Mild cognitive impairment. Continuum (Minneap Minn). 2013 Apr;19(2 Dementia):411-24
Trivedi JK. Cognitive deficits in psychiatric disorders: Current status. Indian J Psychiatry. 2006 Jan;48(1):10-20.
Fleisher A. S., Sowell B. B., Taylor C., Gamst A. C., Petersen R. C., Thal L. J., et al. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 2007;68:1588–1595.
Roberts RO, Cha RH, Mielke MM, Geda YE, Boeve BF, Machulda MM, Knopman DS, Petersen RC. Risk and protective factors for cognitive impairment in persons aged 85 years and older. Neurology. 2015;84(18):1854-61.
Peltz CB, Corrada MM, Berlau DJ, Kawas CH. Cognitive impairment in nondemented oldest-old: prevalence and relationship to cardiovascular risk factors. Alzheimers Dement 2012;8:87–94.
Petersen R.C., Lopez O., Armstrong M.J., et al. Practice guideline update summary: mild cognitive impairment: report of the guideline development, dissemination, and implementation Subcommittee of the American Academy of Neurology. Neurology. 2018;90(3):126–135.
Tisher A., Salardini A. A comprehensive update on treatment of dementia. Semin Neurol. 2019;39(2):167–178.
Mendez M.F., Shapira J.S., McMurtray A., et al. Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia. Am J Geriatr Psychiatry. 2007;15(1):84–87.
McGleenon B.M., Dynan K.B., Passmore A.P. Acetylcholinesterase inhibitors in Alzheimer's disease. Br J Clin Pharmacol. 1999;48(4):471–480.
Kishi T., Matsunaga S., Oya K., et al. Memantine for alzheimer's disease: an updated systematic review and meta-analysis. J Alzheimers Dis. 2017;60(2):401–425.
Orgogozo J.M., Rigaud A.S., Stoffler A., et al. Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300) Stroke. 2002;33(7):1834–1839.
McShane R., Westby M.J., Roberts E., et al. Memantine for dementia. Cochrane Database Syst Rev. 2019;(3) CD003154.
McCollum L, Karlawish J. Cognitive Impairment Evaluation and Management. Med Clin North Am. 2020;104(5):807-825.
Panza G.A., Taylor B.A., MacDonald H.V., et al. Can exercise improve cognitive symptoms of alzheimer's disease? J Am Geriatr Soc. 2018;66(3):487–495.
Zou L., Loprinzi P.D., Yeung A.S., et al. The beneficial effects of mind-body exercises for people with mild cognitive impairment: a systematic review with meta-analysis. Arch Phys Med Rehabil. 2019;100(8):1556–1573.
Woods B., Aguirre E., Spector A.E., et al. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev. 2012;(2) CD005562.
Aguirre E., Woods R.T., Spector A., et al. Cognitive stimulation for dementia: a systematic review of the evidence of effectiveness from randomised controlled trials. Ageing Res Rev. 2013;12(1):253–262.
Sommerlad A., Sabia S., Singh-Manoux A., et al. Association of social contact with dementia and cognition: 28-year follow-up of the Whitehall II cohort study. PLoS Med. 2019;16(8):e1002862.
Fancourt D., Steptoe A., Cadar D. Community engagement and dementia risk: time-to-event analyses from a national cohort study. J Epidemiol Community Health. 2020;74(1):71–77.
Kinnunen K.M., Vikhanova A., Livingston G. The management of sleep disorders in dementia: an update. Curr Opin Psychiatry. 2017;30(6):491–497.
Cassidy-Eagle E., Siebern A., Unti L., et al. Neuropsychological functioning in older adults with mild cognitive impairment and insomnia randomized to CBT-I or Control Group. Clin Gerontol. 2018;41(2):136–144.
Droogsma E., van Asselt D.Z., Scholzel-Dorenbos C.J., et al. Nutritional status of community-dwelling elderly with newly diagnosed Alzheimer's disease: prevalence of malnutrition and the relation of various factors to nutritional status. J Nutr Health Aging. 2013;17(7):606–610.
Cassidy-Eagle E., Siebern A., Unti L., et al. Neuropsychological functioning in older adults with mild cognitive impairment and insomnia randomized to CBT-I or Control Group. Clin Gerontol. 2018;41(2):136–144.
Götz J, Ittner LM. Animal models of Alzheimer's disease and frontotemporal dementia. Nat Rev Neurosci. 2008;9(7):532-44.
Vorhees, C. V., & Williams, M. T. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nature protocols, 2006;1(2), 848-858.
Lord, A., Gumucio, A., Englund, H., Sehlin, D., Sundquist, V. S., Söderberg, L., et al. An amyloid-β protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer’s disease. Neurobiol. Dis. 2009;36:425–434.
Morford LL, Inman-Wood SL, Gudelsky GA, Williams MT, Vorhees CV. Impaired spatial and sequential learning in rats treated neonatally with d-fenfluramine. Eur J Neurosci. 2002;16:491–500.
Brucato FH, Levin ED, Rose JE, Swartzwelder HS. Intracerebroventricular nicotine and mecamylamine alter radial arm maze performance in rats. Drug Dev. Res. 1994;31:18–23.
Morris RGM. Spatial localization does not require the presence of local cues. Learn Motiv. 1981;12:239–260.
Stewart CA, Morris RGM. The watermaze. In: Sahgal A, editor. Behavioural Neuroscience, Volume I, A Practical Approach. IRL Press at Oxford University Press; Oxford: 1993. pp. 107–122.
Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006;1(2):848-58.
Fitzgerald LW, Dokla CP. Morris water task impairment and hypoactivity following cysteamine-induced reductions of somatostatin-like immunoreactivity. Brain Res. 1989;505:246–250.
D’Hooge R, De Deyn PP. Applications of the Morris water maze in the study of learning and memory. Brain Res Rev. 2001;36:60–90.
Bannerman DM, Good MA, Butcher SP, Ramsay M, Morris RGM. Distinct components of spatial learning revealed by prior training and NMDA receptor blockade. Nature. 1995;378:182–186.
Kikusai T, Tonohiro T, Kaneko T. Simultaneous evaluation of spatial working memory and motivation by the allocentric place discrimination task in the water maze in rats. J Vet Med Sci 1999;61:673-81.
Venkataramaiah et al. Morris water maze – a benchmark test for learning and memory disorders in animal models: a review. Asian J Pharm Clin Res, 2018;11:25-29.
Shultz T, Tonkiss J, Galler JR. An analysis of spatial navigation in prenatally protein malnourished rats. Physiol Behav 1994;55:147-78.
Nunez J. Morris Water Maze Experiment. J Vis Exp. 2008 Sep 24;(19):897.
Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods. 1984;11:47–60.
Brandeis R, Brandys Y, Yehuda S. The use of the Morris Water Maze in the study of learning and memory. Int. J. Neurosci. 1989;48:26–69.
Baldan Ramsey, L. C., & Pittenger, C. Cued and spatial learning in the water maze: Equivalent learning in male and female mice. Neuroscience Letters, 2010;483(2), 148–151.
Vorhees, C. V., & Williams, M. T. Assessing spatial learning and memory in rodents. ILAR Journal, 2014;55(2), 310–332.
Hébert, M., Bulla, J., Vivien, D., & Agin, V. Are distal and proximal visual cues equally important during spatial learning in mice? A pilot study of overshadowing in the spatial domain. Frontiers in Behavioral Neuroscience, 2017;11, 109.
Vlasak, A. N. Global and local spatial landmarks: Their role during foraging by Columbian ground squirrels (Spermophilus columbianus). Animal Cognition, 2006;9, 71–80.
McKay, L., Hunninck, L., & Sheriff, M. J. A field-based adaptation of the classic Morris Water Maze to assess learning and memory in a free-living animal. Animal Behavior and Cognition, 2022;9(4), 396-407.
Brandeis R, Brandys Y, Yehuda S. The use of the Morris water maze in the study of memory and learning. Int J Neurosci. 1989;48:29–69.
Othman MZ, Hassan Z, Che Has AT. Morris water maze: a versatile and pertinent tool for assessing spatial learning and memory. Exp Anim. 2022 Aug 5;71(3):264-280.
Vorhees, C. V., & Williams, M. T. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nature protocols, 2006;1(2), 848-858.
D'Hooge, R., & De Deyn, P. P. Applications of the Morris water maze in the study of learning and memory. Brain research reviews, 2001;36(1), 60-90.
Morris RGM, Davis S, Butcher SP. Hippocampal synaptic plasticity and NMDA receptors: A role in information storage? Phil Trans R Soc Lond. 1990;329:187–204